Should I buy or sell Phibro Animal Health stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Phibro Animal Health in the last year. There are currently 1 sell rating, 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" PAHC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PAHC, but not buy additional shares or sell existing shares. View PAHC analyst ratings or view top-rated stocks .

What is Phibro Animal Health's stock price target for 2024?

3 brokerages have issued 1 year price objectives for Phibro Animal Health's stock. Their PAHC share price targets range from $9.00 to $21.00. On average, they expect the company's stock price to reach $15.33 in the next year. This suggests a possible upside of 17.6% from the stock's current price. View analysts price targets for PAHC or view top-rated stocks among Wall Street analysts .

How have PAHC shares performed in 2024?

Phibro Animal Health's stock was trading at $11.58 on January 1st, 2024. Since then, PAHC stock has increased by 12.6% and is now trading at $13.04. View the best growth stocks for 2024 here .

Are investors shorting Phibro Animal Health?

Phibro Animal Health saw a decline in short interest during the month of March. As of March 31st, there was short interest totaling 706,200 shares, a decline of 17.5% from the March 15th total of 855,800 shares. Based on an average daily trading volume, of 145,000 shares, the days-to-cover ratio is presently 4.9 days. Approximately 3.5% of the company's shares are short sold. View Phibro Animal Health's Short Interest .

When is Phibro Animal Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024. View our PAHC earnings forecast .

How were Phibro Animal Health's earnings last quarter?

Phibro Animal Health Co. (NASDAQ:PAHC) released its quarterly earnings results on Wednesday, February, 7th. The company reported $0.33 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.27 by $0.06. The firm earned $249.90 million during the quarter, compared to analysts' expectations of $242.91 million. Phibro Animal Health had a net margin of 1.51% and a trailing twelve-month return on equity of 16.67%.

How often does Phibro Animal Health pay dividends? What is the dividend yield for Phibro Animal Health?

Phibro Animal Health declared a quarterly dividend on Tuesday, February 6th. Investors of record on Wednesday, March 6th will be given a dividend of $0.12 per share on Wednesday, March 27th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 3.68%. The ex-dividend date of this dividend is Tuesday, March 5th. Read our dividend analysis for PAHC .

Is Phibro Animal Health a good dividend stock?

Phibro Animal Health (NASDAQ:PAHC) pays an annual dividend of $0.48 per share and currently has a dividend yield of 3.70%. The dividend payout ratio is 133.33%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, PAHC will have a dividend payout ratio of 39.67% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for PAHC .

What ETF holds Phibro Animal Health's stock?

iShares U.S. Pharmaceuticals ETF holds 27,932 shares of PAHC stock, representing 0.11% of its portfolio.

What guidance has Phibro Animal Health issued on next quarter's earnings?

Phibro Animal Health issued an update on its FY 2024 earnings guidance on Wednesday, February, 7th. The company provided earnings per share (EPS) guidance of 1.040-1.160 for the period, compared to the consensus earnings per share estimate of 1.070. The company issued revenue guidance of $980.0 million-$1.0 billion, compared to the consensus revenue estimate of $990.3 million.

What is Jack Bendheim's approval rating as Phibro Animal Health's CEO?

4 employees have rated Phibro Animal Health Chief Executive Officer Jack Bendheim on Glassdoor.com . Jack Bendheim has an approval rating of 100% among the company's employees. This puts Jack Bendheim in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Phibro Animal Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Phibro Animal Health investors own include Zynga (ZNGA) , Trevena (TRVN) , Endo International (ENDP) , Sonoma Pharmaceuticals (SNOA) , Zynerba Pharmaceuticals (ZYNE) , Intercept Pharmaceuticals (ICPT) , VIVUS (VVUS) , Zoetis (ZTS) , Banco Bradesco (BBD) and Booking (BKNG) .

Who are Phibro Animal Health's major shareholders?

Phibro Animal Health's stock is owned by many different institutional and retail investors. Top institutional investors include Bridge City Capital LLC (0.34%), Allspring Global Investments Holdings LLC (0.20%), Cardinal Capital Management (0.13%) and Los Angeles Capital Management LLC (0.07%). View institutional ownership trends .

How do I buy shares of Phibro Animal Health?

Shares of PAHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:PAHC

Phibro Animal Health (PAHC) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free PAHC Stock Alerts

$13.04

+0.17 (+1.32%)

(As of 04/18/2024 ET)

Compare

Today's Range: $12.84
▼
$13.18
50-Day Range: $11.33
▼
$13.68
52-Week Range: $9.40
▼
$15.98

Volume: 78,597 shs
Average Volume: 143,247 shs
Market Capitalization: $528.12 million

P/E Ratio: 36.22
Dividend Yield: 3.68%
Price Target: $15.33

Get Phibro Animal Health alerts:

Phibro Animal Health MarketRank™ Stock Analysis

Analyst Rating: Hold
2.00 Rating Score
Upside/Downside: 17.6% Upside
$15.33 Price Target
Short Interest: Healthy
3.49% of Float Sold Short
Dividend Strength: Moderate
Based on Four Factors
Sustainability: -3.93
Upright™ Environmental Score
News Sentiment: 0.96
Based on 4 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 8.04%
From $1.12 to $1.21 Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.46 out of 5 stars

Medical Sector

90th out of 918 stocks

Pharmaceutical Preparations Industry

23rd out of 402 stocks

2.0

Analyst's Opinion

Consensus Rating
Phibro Animal Health has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, 1 hold rating, and 1 sell rating.
Amount of Analyst Coverage
Phibro Animal Health has received no research coverage in the past 90 days.

4.0

Short Interest

Percentage of Shares Shorted
3.49% of the float of Phibro Animal Health has been sold short.
Short Interest Ratio / Days to Cover
Phibro Animal Health has a short interest ratio ("days to cover") of 4.9.
Change versus previous month
Short interest in Phibro Animal Health has recently decreased by 17.48%, indicating that investor sentiment is improving significantly.

2.5

Dividend Strength

Dividend Leadership
Phibro Animal Health is a leading dividend payer. It pays a dividend yield of 3.70%, putting its dividend yield in the top 25% of dividend-paying stocks.
Dividend Growth
Phibro Animal Health does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Phibro Animal Health is 133.33%. Payout ratios above 75% are not desirable because they may not be sustainable.
Dividend Sustainability
Based on earnings estimates, Phibro Animal Health will have a dividend payout ratio of 39.67% next year. This indicates that Phibro Animal Health will be able to sustain or increase its dividend.

1.1

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Phibro Animal Health has received a -45.84% net impact score from Upright. The largest negative impact of Phibro Animal Health in category "GHG emissions" seems to be driven mostly by its "Animal feed supplements", "Cattle vaccines", and "Poultry vaccines" products. See details.
Environmental Sustainability
The Environmental Impact score for Phibro Animal Health is -3.93.

3.9

News and Social Media Coverage

News Sentiment
Phibro Animal Health has a news sentiment score of 0.96. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.49 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 4 news articles for Phibro Animal Health this week, compared to 2 articles on an average week.
Search Interest
1 people have searched for PAHC on MarketBeat in the last 30 days.
MarketBeat Follows
1 people have added Phibro Animal Health to their MarketBeat watchlist in the last 30 days.

3.3

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Phibro Animal Health insiders have not sold or bought any company stock.
Percentage Held by Insiders
50.06% of the stock of Phibro Animal Health is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
99.34% of the stock of Phibro Animal Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5

Earnings and Valuation

Earnings Growth
Earnings for Phibro Animal Health are expected to grow by 8.04% in the coming year, from $1.12 to $1.21 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Phibro Animal Health is 36.22, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 142.54.
Price to Earnings Ratio vs. Sector
The P/E ratio of Phibro Animal Health is 36.22, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 231.05.
Price to Earnings Growth Ratio
Phibro Animal Health has a PEG Ratio of 4.81. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Phibro Animal Health has a P/B Ratio of 1.87. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About Phibro Animal Health Stock (NASDAQ:PAHC)

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, industrial, environmental, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.

PAHC Stock Price History

30 days | 90 days | 365 days | Advanced Chart

PAHC Stock News Headlines

April 18, 2024 | businesswire.com

Phibro Animal Health Corporation to Host Webcast and Conference Call on Third Quarter Results

April 15, 2024 | americanbankingnews.com

Short Interest in Phibro Animal Health Co. (NASDAQ:PAHC) Drops By 17.5%

April 18, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

April 13, 2024 | investing.com

Phibro Animal Health Corporation (PAHC)

April 9, 2024 | finance.yahoo.com

Phibro Animal Health Corporation (NASDAQ:PAHC) Shares Could Be 28% Below Their Intrinsic Value Estimate

April 9, 2024 | americanbankingnews.com

Phibro Animal Health (NASDAQ:PAHC) Lifted to Buy at StockNews.com

March 27, 2024 | seekingalpha.com

PAHC Phibro Animal Health Corporation

March 8, 2024 | msn.com

Why Is Phibro (PAHC) Up 12.7% Since Last Earnings Report?

April 18, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

March 8, 2024 | finance.yahoo.com

Should We Be Cautious About Phibro Animal Health Corporation's (NASDAQ:PAHC) ROE Of 5.5%?

February 29, 2024 | businesswire.com

Phibro Animal Health Corporation to Participate in Barclays Global Healthcare Conference

February 22, 2024 | benzinga.com

Phibro Animal Health Stock (NASDAQ:PAHC), Quotes and News Summary

February 14, 2024 | finance.yahoo.com

Phibro Animal Health Corporation to Participate in Bank of America 2024 Animal Health Summit

February 14, 2024 | businesswire.com

Phibro Animal Health Corporation to Participate in Bank of America 2024 Animal Health Summit

February 14, 2024 | finance.yahoo.com

What Makes Phibro (PAHC) a New Buy Stock

February 10, 2024 | finance.yahoo.com

Richard Pzena Trims Stake in Phibro Animal Health Corp

February 9, 2024 | benzinga.com

Phibro Animal Health Stock (NASDAQ:PAHC) Earnings Dates and Earning Calls

February 9, 2024 | finance.yahoo.com

Phibro Animal Health Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

February 9, 2024 | finance.yahoo.com

Phibro Animal Health Corporation (NASDAQ:PAHC) Q2 2024 Earnings Call Transcript

February 9, 2024 | finance.yahoo.com

Q2 2024 Phibro Animal Health Corp Earnings Call

February 8, 2024 | finance.yahoo.com

Phibro (PAHC) Q2 Earnings and Revenues Top, Margins Down

February 7, 2024 | finance.yahoo.com

Phibro Animal Health (PAHC) Surpasses Q2 Earnings and Revenue Estimates

February 7, 2024 | finance.yahoo.com

Phibro (PAHC) Reports Q2 Earnings: What Key Metrics Have to Say

February 7, 2024 | finance.yahoo.com

Phibro Animal Health Corporation Reports Second Quarter Results, Updates Financial Guidance

February 7, 2024 | finance.yahoo.com

Phibro Animal Health Corp (PAHC) Reports Mixed Q2 Results and Revises FY2024 Guidance

February 7, 2024 | msn.com

Phibro Appoints New CFO in Strategic Leadership Update

February 6, 2024 | finance.yahoo.com

Phibro Animal Health Corporation Declares Quarterly Dividend

See More Headlines

Receive PAHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Phibro Animal Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/07/2024
Ex-Dividend for 3/27 Dividend: 3/05/2024
Dividend Payable: 3/27/2024
Today: 4/18/2024
Next Earnings (Estimated): 5/01/2024
Fiscal Year End: 6/30/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Current Symbol: NASDAQ:PAHC
CUSIP: N/A
CIK: 1069899
Web: www.pahc.com
Phone: (201) 329-7300
Fax: 201-329-7399
Employees: 1,920
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $15.33
High Stock Price Target: $21.00
Low Stock Price Target: $9.00
Potential Upside/Downside: +17.3%
Consensus Rating: Hold
Rating Score (0-4): 2.00
Research Coverage: 3 Analysts

Profitability

EPS (Most Recent Fiscal Year): $0.36
Trailing P/E Ratio: 36.31
Forward P/E Ratio: 11.67
P/E Growth: 4.81
Net Income: $32.61 million
Net Margins: 1.51%
Pretax Margin: 2.87%
Return on Equity: 16.67%
Return on Assets: 4.73%

Debt

Debt-to-Equity Ratio: 1.66
Current Ratio: 3.12
Quick Ratio: 1.60

Sales & Book Value

Annual Sales: $977.90 million
Price / Sales: 0.54
Cash Flow: $2.08 per share
Price / Cash Flow: 6.28
Book Value: $6.97 per share
Price / Book: 1.88

Miscellaneous

Outstanding Shares: 40,500,000
Free Float: 20,227,000
Market Cap: $529.34 million
Optionable: Optionable
Beta: 0.75

Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

Mr. Jack Clifford Bendheim (Age 77)
Chairman, President & CEO
Comp: $2.9M
Mr. Larry L. Miller (Age 60)
Chief Operating Officer
Comp: $774.91k
Mr. Daniel M. Bendheim (Age 52)
Executive VP of Corporate Strategy & Director
Comp: $548.18k
Mr. Rob Aukerman (Age 66)
President of North America Region
Comp: $619.27k
Mr. Glenn C. David (Age 51)
Chief Financial Officer
Ms. Judith A. Weinstein (Age 55)
Senior VP, General Counsel & Corporate Secretary
Ms. Lisa A. Escudero (Age 62)
Senior Vice President of Human Resources
Mr. Jonathan Bendheim (Age 48)
President of MACIE Region, GM of Israel Operations & Director
Mr. Ramon Fuenmayor
President South America Region
Mr. Samson Li (Age 52)
President of Asia Pacific Region

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

PAHC Stock Analysis - Frequently Asked Questions

Should I buy or sell Phibro Animal Health stock right now?: 3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Phibro Animal Health in the last year. There are currently 1 sell rating, 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" PAHC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PAHC, but not buy additional shares or sell existing shares.
View PAHC analyst ratings or view top-rated stocks.
What is Phibro Animal Health's stock price target for 2024?: 3 brokerages have issued 1 year price objectives for Phibro Animal Health's stock. Their PAHC share price targets range from $9.00 to $21.00. On average, they expect the company's stock price to reach $15.33 in the next year. This suggests a possible upside of 17.6% from the stock's current price.
View analysts price targets for PAHC or view top-rated stocks among Wall Street analysts.
How have PAHC shares performed in 2024?: Phibro Animal Health's stock was trading at $11.58 on January 1st, 2024. Since then, PAHC stock has increased by 12.6% and is now trading at $13.04.
View the best growth stocks for 2024 here.
Are investors shorting Phibro Animal Health?: Phibro Animal Health saw a decline in short interest during the month of March. As of March 31st, there was short interest totaling 706,200 shares, a decline of 17.5% from the March 15th total of 855,800 shares. Based on an average daily trading volume, of 145,000 shares, the days-to-cover ratio is presently 4.9 days. Approximately 3.5% of the company's shares are short sold.
View Phibro Animal Health's Short Interest.
When is Phibro Animal Health's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our PAHC earnings forecast.
How were Phibro Animal Health's earnings last quarter?: Phibro Animal Health Co. (NASDAQ:PAHC) released its quarterly earnings results on Wednesday, February, 7th. The company reported $0.33 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.27 by $0.06. The firm earned $249.90 million during the quarter, compared to analysts' expectations of $242.91 million. Phibro Animal Health had a net margin of 1.51% and a trailing twelve-month return on equity of 16.67%.
How often does Phibro Animal Health pay dividends? What is the dividend yield for Phibro Animal Health?: Phibro Animal Health declared a quarterly dividend on Tuesday, February 6th. Investors of record on Wednesday, March 6th will be given a dividend of $0.12 per share on Wednesday, March 27th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 3.68%. The ex-dividend date of this dividend is Tuesday, March 5th.
Read our dividend analysis for PAHC.
Is Phibro Animal Health a good dividend stock?: Phibro Animal Health (NASDAQ:PAHC) pays an annual dividend of $0.48 per share and currently has a dividend yield of 3.70%. The dividend payout ratio is 133.33%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, PAHC will have a dividend payout ratio of 39.67% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for PAHC.

What ETF holds Phibro Animal Health's stock?: iShares U.S. Pharmaceuticals ETF holds 27,932 shares of PAHC stock, representing 0.11% of its portfolio.
What guidance has Phibro Animal Health issued on next quarter's earnings?: Phibro Animal Health issued an update on its FY 2024 earnings guidance on Wednesday, February, 7th. The company provided earnings per share (EPS) guidance of 1.040-1.160 for the period, compared to the consensus earnings per share estimate of 1.070. The company issued revenue guidance of $980.0 million-$1.0 billion, compared to the consensus revenue estimate of $990.3 million.
What is Jack Bendheim's approval rating as Phibro Animal Health's CEO?: 4 employees have rated Phibro Animal Health Chief Executive Officer Jack Bendheim on Glassdoor.com. Jack Bendheim has an approval rating of 100% among the company's employees. This puts Jack Bendheim in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of Phibro Animal Health own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Phibro Animal Health investors own include Zynga (ZNGA), Trevena (TRVN), Endo International (ENDP), Sonoma Pharmaceuticals (SNOA), Zynerba Pharmaceuticals (ZYNE), Intercept Pharmaceuticals (ICPT), VIVUS (VVUS), Zoetis (ZTS), Banco Bradesco (BBD) and Booking (BKNG).
Who are Phibro Animal Health's major shareholders?: Phibro Animal Health's stock is owned by many different institutional and retail investors. Top institutional investors include Bridge City Capital LLC (0.34%), Allspring Global Investments Holdings LLC (0.20%), Cardinal Capital Management (0.13%) and Los Angeles Capital Management LLC (0.07%).
View institutional ownership trends.
How do I buy shares of Phibro Animal Health?: Shares of PAHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:PAHC) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Phibro Animal Health (PAHC) Stock Price, News & Analysis

Phibro Animal Health MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Phibro Animal Health Stock (NASDAQ:PAHC)

PAHC Stock Price History

PAHC Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Institutional Ownership

PAHC Stock Analysis - Frequently Asked Questions

Overall MarketRank^™